Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$9.31 -0.08 (-0.85%)
At close: Nov 11, 2026 · 4:00 PM EST

Arcturus Therapeutics Holdings (ARCT) Long-Term Debt Repayments (2022 - 2023)

Updated

Arcturus Therapeutics Holdings' Long-Term Debt Repayments came in at $15 million for FY2025.

Analysis

Arcturus Therapeutics Holdings (ARCT) Long-Term Debt Repayments (2022 - 2023) Analysis & Trends

  • Long-Term Debt Repayments carries a three-year compound annual growth rate of 44.2% (FY2022 to FY2025).
  • The FY2025 figure represents the lowest annual Long-Term Debt Repayments since FY2022.
  • Per Business Quant, earlier years put Long-Term Debt Repayments at $47.36 million in FY2023 (+847.3%) and $5 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Arcturus Therapeutics Holdings 267.25 Mn -551.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 20.00 Mn
Mar 31, 2023 27.36 Mn
Dec 31, 2022 3.00 Mn
API Access

Arcturus Therapeutics Holdings Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ARCT&period=max&api_key=YOUR_API_KEY